Trellis Bioscience
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Trellis Bioscience sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Trellis Bioscience: 4 sponsored US clinical trials, 1 recruiting.
Trellis Bioscience sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prosthetic Joint Infections of Knee, with 1 trials.
Upper-quartile sponsor footprint
Trellis Bioscience sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection
NCT06621251
Study to Evaluate Safety and Activity of Inhaled TRL1068 in Healthy Volunteers
NCT07644195
Study to Evaluate Safety and Activity of TRL345 in Healthy Volunteers
NCT05408091
Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint Infections
NCT04763759
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Trellis Bioscience pipeline
1 recruiting of 4 indexed (25% open); 2 completed (50%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Prosthetic Joint Infections of Knee (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Trellis Bioscience: open-pipeline peers nationwide
Peers matched on 4 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
Trellis Bioscience sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 25% open enrollment (± trial volume)
- AB Science · 25% recruiting · 8 trials
- Abbott Point of Care · 25% recruiting · 8 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
- Adrienne G. Waks · 25% recruiting · 4 trials
Related
What to do with this Trellis Bioscience page
4 registered trials is a research-attention snapshot, not an endorsement of Trellis Bioscience or any single study.
- 1 of Trellis Bioscience's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prosthetic Joint Infections of Knee is the condition Trellis Bioscience studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prosthetic Joint Infections of Knee trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Trellis Bioscience pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.